Registration Strip Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.

NDRA ENDRA Life Sciences Inc

0.00 (0.0%)
Dec 05 2023 - Closed
Delayed by 15 minutes
Company Name Stock Ticker Symbol Market Type
ENDRA Life Sciences Inc NDRA NASDAQ Common Stock
  Price Change Change Percent Stock Price Last Traded
0.00 0.0% 1.34 19:00:00
Open Price Low Price High Price Close Price Prev Close
more quote information »

Recent News

Date Time Source Heading
12/05/20239:35IHNWFeaturedInternational Lithium: PEA for the Raleigh Lake Lithium Project Outlines Highly Favourable After-Tax NPV (Discounted at 8%) of CAD$342.9 million and After-Tax IRR of 44.3% P.A.
12/05/20237:30IHNWFeaturedProspera Energy Inc. Secures $3.5 Million in Development Financing and Announces Strategic Appointments to Strengthen Leadership Team
11/29/202308:00BWENDRA Life Sciences Secures 39th U.S. Patent for TAEUS®..
11/27/202308:00BWENDRA Life Sciences to Participate in The Benchmark..
11/14/202316:05BWENDRA Life Sciences Reports Third Quarter 2023 Financial..
11/14/202316:02EDGAR2Form 8-K - Current report
11/08/202308:00BWENDRA Life Sciences Achieves Intellectual Property Milestone..
11/07/202316:05BWENDRA Life Sciences to Report Third Quarter 2023 Financial..
11/06/202308:00BWENDRA to Host Multidisciplinary Clinical Discussion on..
9/07/202308:00BWAbstract for ENDRA Life Sciences' TAEUS System Accepted for..
8/30/202308:00BWENDRA Life Sciences' TAEUS De Novo Submission Advances to..
8/23/202308:00BWENDRA Life Sciences Expands Intellectual Property with..
8/14/202316:53EDGAR2Form 424B5 - Prospectus [Rule 424(b)(5)]
8/14/202316:45EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
8/14/202316:13EDGAR2Form 8-K - Current report
8/14/202316:05BWENDRA Life Sciences Reports Second Quarter 2023 Financial..
8/14/202313:30BWENDRA Life Sciences Submits De Novo Request for its TAEUS®..
8/10/202308:01EDGAR2Form 8-K - Current report
8/01/202308:00BWENDRA Life Sciences to Report Second Quarter 2023 Financial..
7/25/202316:02EDGAR2Form 8-K - Current report
7/06/202317:25EDGAR2Form 8-K - Current report
7/06/202317:25EDGAR2Form DEFA14A - Additional definitive proxy soliciting..
7/06/202316:45BWENDRA Life Sciences Announces Adjournment of 2023 Annual..
6/07/202308:00BWStudy Highlighting ENDRA Life Sciences’ TAEUS Technology to..
5/15/202316:05BWENDRA Life Sciences Reports First Quarter 2023 Financial..
5/04/202308:00BWENDRA Life Sciences to Report First Quarter 2023 Financial..
5/02/202316:01BWENDRA Life Sciences Announces Closing of Public Offering and..
4/28/202308:00BWENDRA Life Sciences Announces Pricing of Upsized $4.5..
3/14/202316:05BWENDRA Life Sciences Reports Fourth Quarter and Full Year..
3/07/202316:05BWENDRA Life Sciences to Report Fourth Quarter and Full Year..

Your Recent History

Delayed Upgrade Clock